| Group; variable | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Disease; rate per 100 000 population | |||||||||||||
| All liver disease | HBV infection | HCV infection | Primary liver cancer | ||||||||||
| Crude | Age-standardized (95% CI) | Crude | Age-standardized (95% CI) | Crude | Age-standardized (95% CI) | Crude | Age-standardized (95% CI) | ||||||
| Canadian-born | 75.4 | 77.8 (75.8-79.9) | 2.6 | 2.7 (2.3-3.1) | 6.2 | 6.3 (5.8-7.3) | 7.3 | 7.7 (7.1-8.4) | |||||
| Immigrant | 66.4 | 59.8* (57.1-62.7) | 5.1 | 4.7* (3.9-5.6) | 5.5 | 5.0* (4.2-5.9) | 12.4 | 10.6* (9.5-11.8) | |||||
| Duration of residence, yr | |||||||||||||
| > 10 | 79.8 | 65.0* (61.7-68.5) | 5.8 | 5.1* (4.2-6.2) | 6.5 | 5.3* (4.4-6.3) | 14.9 | 10.9* (9.6-12.3) | |||||
| ≤ 10 | 26.9 | 45.2* (38.1-53.7) | 2.8 | 5.4 (3.2-9.2) | 2.8 | 4.5 (2.7-7.5) | 5.9 | 15.7* (11.3-22.9) | |||||
| Source country risk level | |||||||||||||
| Low | - | - | 2.0 | 1.7* (1.0-2.7) | 5.4 | 4.6* (3.8-5.5) | 10.7 | 7.8 (6.7-9.0) | |||||
| Medium | - | - | 2.9 | 3.0 (2.0-4.4) | 2.1 | 2.1* (1.1-4.1) | - | - | |||||
| High | - | - | 11.4 | 12.5* (10.2-15.5) | 17.9 | 23.0* (15.3-34.5) | 16.8 | 20.0* (16.9-23.6) | |||||
Note: CI = confidence interval, HBV = hepatitis B virus, HCV = hepatitis C virus.
*Significantly different from the value for the Canadian-born cohort.